NCT00648128View on ClinicalTrials.gov

Comparative Bioavailability Study of Clarithromycin 500 mg Tablets in Fed State

PHASE1CompletedINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

March 31, 2003

Primary Completion Date

March 31, 2003

Study Completion Date

March 31, 2003

Conditions
Healthy
Interventions
DRUG

Clarithromycin

Single-dose 500 mg immediate-release oral tablet

DRUG

Clarithromycin

single-dose 500 mg immediate-release oral dose'

Trial Locations (1)

H7V 4B4

Algorithme Pharma, Laval

Sponsors

Collaborators (1)

Genpharm ULC
All Listed Sponsors
collaborator

Genpharm ULC

INDUSTRY

lead

Mylan Pharmaceuticals Inc

INDUSTRY

NCT00648128 - Comparative Bioavailability Study of Clarithromycin 500 mg Tablets in Fed State | Biotech Hunter | Biotech Hunter